Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients [Phase 1]
Phase 1 clinical trial update examining whether structured telephone communication between acute care and long-term care physicians improves…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease [Phase 1]
A Phase 1 multiple-dose intravenous study of PF-04360365 in Japanese patients with mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) [Phase 4]
This ClinicalTrials.gov entry reports a Phase 4, multicenter, open-label evaluation of the clinical effectiveness of the once-daily rivastig…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 [EARLY_Phase 1]
This early-phase study reports initial safety and imaging efficacy data for the PET radioligand MNI-558 in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease [Phase 2]
Phase 2 study evaluating the efficacy and safety of Tamibarotene (OAM80) for Alzheimer's disease; this update summarizes the ongoing results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of EVP-6124 in Alzheimer's disease completed; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease
A completed observational study assessing long-term immunogenicity and potential efficacy of the UB-311 vaccine in individuals with Alzheime…
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease [NA]
This document provides an update on a clinical trial evaluating the safety and efficacy of magnetic fields for the treatment of Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating the safety of switching from donepezil to rivastigmine patch in patients with probable Alzheimer's disease; results…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of galantamine hydrobromide for severe Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-13Clinical Trial Update: An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of INM-176 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Phase 3]
This Phase 3 trial update reports the completion of a study evaluating the efficacy and safety of Galantamine in patients with Mild Cognitiv…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Phase 3]
Phase 3 trial evaluating the efficacy and safety of galantamine in patients with mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease [Phase 4]
A completed Phase 4 study comparing galantamine and donepezil in Alzheimer's disease, assessing effects on sleep, attention, and gastrointes…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease [Phase 4]
Phase 4 clinical trial evaluating memantine's effect on brain atrophy in Alzheimer's disease has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders [NA]
A non-pharmacological treatment study for Alzheimer's disease and associated disorders sponsored by Centre Hospitalier Universitaire de Nice…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
Phase 3 results report on the efficacy and safety of rivastigmine transdermal patch in patients with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease [Phase 3]
This Phase 3 trial comparing risperidone to placebo for hallucinations and delusions in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation [Phase 3]
A Phase 3 placebo-controlled trial evaluated the safety and efficacy of a controlled-release formulation of galantamine for Alzheimer’s dise…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease [Phase 3]
This is a completed Phase 3 safety and tolerability trial of extended-release galantamine in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease [Phase 3]
A Phase 3 randomized, double-blind trial evaluated the effectiveness and safety of immediate-release galantamine in mild-to-moderate Alzheim…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
A Phase 3 trial comparing two doses of galantamine to placebo in Alzheimer's disease has completed, evaluating safety and effectiveness.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 study comparing a flexible-dose galantamine regimen to placebo in patients with Alzheimer's disease to assess safety and effectivene…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Phase 3]
This Phase 3 trial evaluated the safety and effectiveness of galantamine versus placebo in patients with vascular dementia or mixed dementia…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 clinical trial comparing two doses of galantamine to placebo in Alzheimer's disease to evaluate safety and effectiveness; the study …